•
Sep 30, 2023

Elevance Health Q3 2023 Earnings Report

Elevance Health reported strong financial performance driven by its diversified portfolio and strategic investments.

Key Takeaways

Elevance Health reported a solid third quarter with adjusted net income of $8.99 per share and operating revenue of $42.5 billion. The company is increasing its full-year earnings outlook based on year-to-date outperformance.

GAAP net income was $5.45 per share, including net negative adjustment items of $3.54 per share.

Adjusted net income was $8.99 per share.

Operating gain, excluding adjustment items, grew 12.6% year-over-year to $2.5 billion.

Operating cash flow was $2.6 billion.

Total Revenue
$42.5B
Previous year: $39.6B
+7.2%
EPS
$8.99
Previous year: $7.53
+19.4%
Total Medical Membership
47.3M
Previous year: 47.3M
+0.0%
Gross Profit
$38.2B
Previous year: $36.5B
+4.7%
Cash and Equivalents
$10.9B
Previous year: $8.87B
+23.1%
Free Cash Flow
$2.29B
Previous year: $4.62B
-50.3%
Total Assets
$110B
Previous year: $103B
+7.2%

Elevance Health

Elevance Health

Elevance Health Revenue by Segment

Forward Guidance

The Company now expects GAAP net income to be greater than $26.40 per share in 2023, and adjusted net income to be greater than $33.00 per share.